RFG Advisory’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $571K | Buy |
6,228
+388
| +7% | +$33.9K | 0.01% | 755 |
|
|
2026
Q1 | $498K | Buy |
5,840
+88
| +2% | +$7.84K | 0.01% | 746 |
|
|
2025
Q4 | $455K | Sell |
5,752
-1,205
| -17% | -$94.5K | 0.01% | 741 |
|
|
2025
Q3 | $556K | Sell |
6,957
-2,270
| -25% | -$194K | 0.01% | 636 |
|
|
2025
Q2 | $839K | Buy |
9,227
+123
| +1% | +$11.2K | 0.02% | 481 |
|
|
2025
Q1 | $853K | Buy |
9,104
+4,199
| +86% | +$376K | 0.02% | 437 |
|
|
2024
Q4 | $446K | Sell |
4,905
-409
| -8% | -$39K | 0.01% | 550 |
|
|
2024
Q3 | $552K | Sell |
5,314
-97
| -2% | -$9.89K | 0.02% | 489 |
|
|
2024
Q2 | $525K | Buy |
5,411
+112
| +2% | +$10.3K | 0.02% | 484 |
|
|
2024
Q1 | $477K | Buy |
5,299
+317
| +6% | +$26.9K | 0.02% | 513 |
|
|
2023
Q4 | $397K | Sell |
4,982
-93
| -2% | -$6.99K | 0.02% | 486 |
|
|
2023
Q3 | $361K | Buy |
5,075
+53
| +1% | +$3.96K | 0.02% | 472 |
|
|
2023
Q2 | $387K | Sell |
5,022
-156
| -3% | -$12.1K | 0.02% | 474 |
|
|
2023
Q1 | $389K | Sell |
5,178
-403
| -7% | -$30K | 0.02% | 460 |
|
|
2022
Q4 | $415K | Sell |
5,581
-571
| -9% | -$42.8K | 0.02% | 449 |
|
|
2022
Q3 | $454K | Buy |
6,152
+1,063
| +21% | +$83.4K | 0.03% | 402 |
|
|
2022
Q2 | $409K | Buy |
5,089
+231
| +5% | +$18.1K | 0.02% | 393 |
|
|
2022
Q1 | $368K | Sell |
4,858
-485
| -9% | -$38.4K | 0.02% | 383 |
|
|
2021
Q4 | $456K | Buy |
5,343
+586
| +12% | +$45.8K | 0.03% | 322 |
|
|
2021
Q3 | $360K | Buy |
4,757
+41
| +0.9% | +$3.26K | 0.03% | 318 |
|
|
2021
Q2 | $384K | Sell |
4,716
-166
| -3% | -$13.6K | 0.03% | 310 |
|
|
2021
Q1 | $385K | Buy |
4,882
+690
| +16% | +$54.1K | 0.04% | 291 |
|
|
2020
Q4 | $345K | Sell |
4,192
-253
| -6% | -$20.9K | 0.05% | 303 |
|
|
2020
Q3 | $343K | Buy |
4,445
+108
| +2% | +$8.23K | 0.05% | 288 |
|
|
2020
Q2 | $318K | Buy |
4,337
+123
| +3% | +$8.74K | 0.05% | 278 |
|
|
2020
Q1 | $280K | Buy |
4,214
+157
| +4% | +$11.1K | 0.05% | 269 |
|
|
2019
Q4 | $279K | Buy |
4,057
+131
| +3% | +$8.93K | 0.05% | 301 |
|
|
2019
Q3 | $289K | Sell |
3,926
-72
| -2% | -$5.22K | 0.06% | 254 |
|
|
2019
Q2 | $286K | Buy |
3,998
+257
| +7% | +$18.2K | 0.07% | 244 |
|
|
2019
Q1 | $256K | Sell |
3,741
-2,600
| -41% | -$168K | 0.07% | 218 |
|
|
2018
Q4 | $377K | Buy |
6,341
+1,017
| +19% | +$63.6K | 0.09% | 175 |
|
|
2018
Q3 | $356K | Buy |
5,324
+1,508
| +40% | +$100K | 0.09% | 196 |
|
|
2018
Q2 | $247K | Buy |
+3,816
| New | +$250K | 0.07% | 177 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
RFG Advisory's CL Position: Q2 2026 in Review
RFG Advisory increased its Colgate-Palmolive (CL) stake by 6.6% in Q2 2026, buying an estimated $33.9K and bringing the position to 6,228 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #755.
RFG Advisory first reported a position in CL in Q2 2018 and has held it in 33 quarters since. The position peaked at $853K in Q1 2025. 640 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- RFG Advisory held 6,228 shares of Colgate-Palmolive worth $571K as of Q2 2026.
- RFG Advisory bought 388 Colgate-Palmolive shares in Q2 2026, an estimated $33.9K.
- Colgate-Palmolive made up 0.01% of RFG Advisory's portfolio in Q2 2026, its #755 holding.
- RFG Advisory first reported a position in Colgate-Palmolive in Q2 2018 and has held it in 33 quarters since.
- RFG Advisory's Colgate-Palmolive position peaked at $853K in Q1 2025.
- 640 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.